Chemistry of inorganic compounds – Silicon or compound thereof – Oxygen containing
Patent
1990-09-13
1992-10-13
Waddell, Frederick E.
Chemistry of inorganic compounds
Silicon or compound thereof
Oxygen containing
423331, 514121, 514566, A61K 3166, A61K 31195, C01B 3320, C01B 3324
Patent
active
051549034
ABSTRACT:
This invention pertains to an improved method of inhibiting peroxide-reduction catalytic activity and concomitant toxicity of asbestos and nonasbestos iron-containing silicates. These undesirable reactions can be substantially reduced or essentially eliminated by contacting these potentially harmful materials with an aqueous solution comprising a non-mutagenic non-toxic iron chelating agent, such as phytic acid, diethylenetriamine pentaacetic acid (DTPA) or derivatives of these.
REFERENCES:
patent: 4474742 (1984-10-01), Graceffa et al.
Rasmussen, L. et al., In Vitro Cell Dev Biol 22(4):177-179 (Apr. 1986).
Vullo, C. et al., Haematologica 74 (5 Suppl): 241-25) (Oct. 1989).
Waxman, H. S. et al., Prog Hematol 6:338-373 (1969).
Winston, G. W. et al., Arch Biochem Biophys 232(1):378-390 (Jul. 1984).
Henriksson, R. et al., Cancer Lett. 43(3):179-183 (Dec. 15, 1988).
Morehouse, L. A. et al., Arch Biochem Biophys 232(1):366-377 (Jul. 1984).
Pippard, M. J. et al., Scand J Haematol 36(5):466-472 (May 1986).
Pitt, C. G. et al., "Development of Iron Chelators for Clinical Use" Nih, Bethesda (1976).
Timbrell, V., "Characteristics of the International Union Against Cancer Standard Reference Samples of Asbestos", pp. 2-10 (1969).
De Waele, J. K. and F. C. Adams, Scanning Microscopy 2:209-228 (1988).
Harrington, J. S., Annals New York Academy of Sciences, 132:31-47 (1965).
Pooley, F. D., Seminars in Oncology, 8:243-249 (1981).
Weitzman, S. A. and P. Graceffa, Arch. Biochem. Biophys. 228:373-376 (1984).
Graf, E. et al., J. Biol. Chem. 259:3620-3624 (1984).
Zalma, R. et al., Can. J. Chem. 65:2338-2341 (1988).
Kennedy, T. P. et al., Arch. Biochem. Biophys. 269:359-364 (1989).
Graf, E., JAOCS 60:1861-1867 (1983).
Graf, E. and J. W. Eaton, Cancer 56:717-718 (1985).
Gulumian, M. and J. A. Van Wyk Chem. Biol. Interactions 62:89-97 (1987).
Graceffa Philip J.
Weitzman Sigmund A.
Boston Biomedical Research Institute
Gardner Diane
Massachusetts General Hospital
Waddell Frederick E.
LandOfFree
Treatment of asbestos and silicates to reduce their toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of asbestos and silicates to reduce their toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of asbestos and silicates to reduce their toxicity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1298902